Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1986 1
1988 2
1989 29
1990 5
1991 4
1992 28
1993 13
1994 18
1995 17
1996 28
1997 45
1998 42
1999 49
2000 52
2001 58
2002 74
2003 67
2004 83
2005 66
2006 69
2007 73
2008 56
2009 54
2010 43
2011 41
2012 38
2013 39
2014 27
2015 31
2016 18
2017 17
2018 17
2019 8
2020 6
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

1,133 results
Results by year
Filters applied: . Clear all
Page 1
Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial.
Jacobsen P, Zhong W, Nomikos G, Clayton A. Jacobsen P, et al. J Sex Med. 2019 Oct;16(10):1638-1649. doi: 10.1016/j.jsxm.2019.06.018. Epub 2019 Aug 9. J Sex Med. 2019. PMID: 31405765 Free article. Clinical Trial.
Non-compliance appeared to influence results, particularly the paroxetine and vortioxetine 20 mg arms. Paroxetine, but not vortioxetine, was associated with statistically significantly more TESD vs placebo. ...Assay sensitivity was demonstrated by statistically sign …
Non-compliance appeared to influence results, particularly the paroxetine and vortioxetine 20 mg arms. Paroxetine, but not vor …
Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial.
Abu El-Hamd M, Abdelhamed A. Abu El-Hamd M, et al. Andrologia. 2018 Feb;50(1). doi: 10.1111/and.12829. Epub 2017 May 12. Andrologia. 2018. PMID: 28497478 Clinical Trial.
The aim of the study was to compare the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation (PE). ...The combined dapoxetine with sildenafil ther …
The aim of the study was to compare the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and c …
Paroxetine, Cognitive Therapy or Their Combination in the Treatment of Social Anxiety Disorder with and without Avoidant Personality Disorder: A Randomized Clinical Trial.
Nordahl HM, Vogel PA, Morken G, Stiles TC, Sandvik P, Wells A. Nordahl HM, et al. Psychother Psychosom. 2016;85(6):346-356. doi: 10.1159/000447013. Epub 2016 Oct 15. Psychother Psychosom. 2016. PMID: 27744447 Free article. Clinical Trial.
METHODS: A total of 102 patients were randomly assigned to paroxetine, CT, the combination of CT and paroxetine, or pill placebo. ...At the 12-month follow-up, the CT group maintained benefits and was significantly better than placebo and paroxetine alone, wh …
METHODS: A total of 102 patients were randomly assigned to paroxetine, CT, the combination of CT and paroxetine, or pill place …
Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - The "TRAKT" study.
Popiel A, Zawadzki B, Pragłowska E, Teichman Y. Popiel A, et al. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. Epub 2015 Jan 28. J Behav Ther Exp Psychiatry. 2015. PMID: 25677254 Clinical Trial.
This is the first randomized clinical trial comparing the efficacy of prolonged exposure (PE), paroxetine (Ph) and their combination (Comb) in a sample of adults diagnosed with PTSD following motor vehicle accidents (MVA). ...CONCLUSIONS: In this, largest to date study com …
This is the first randomized clinical trial comparing the efficacy of prolonged exposure (PE), paroxetine (Ph) and their combination …
[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].
Horváth S, Karányi Z, Harcos P, Nagy Z, Németh G, Andor G. Horváth S, et al. Orv Hetil. 2006 Dec 17;147(50):2397-404. Orv Hetil. 2006. PMID: 17274185 Clinical Trial. Hungarian.
Treatment of depression positively correlated with the success of rehabilitation, quality of life, and the post-stroke patient's independence. AIM: The primary goal of the study was to establish the therapeutic efficacy of paroxetine (measured by the changes of Hami …
Treatment of depression positively correlated with the success of rehabilitation, quality of life, and the post-stroke patient's inde …
Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
Waintraub L, Septien L, Azoulay P. Waintraub L, et al. CNS Drugs. 2002;16(1):65-75. doi: 10.2165/00023210-200216010-00005. CNS Drugs. 2002. PMID: 11772119 Clinical Trial.
INTERVENTIONS: Patients were treated with either tianeptine (12.5mg three times daily) or paroxetine (20mg once daily plus two placebo capsules). The drug dosages could be doubled after 3 weeks if required by the patient's medical state. ...CONCLUSION: Tianeptine ap …
INTERVENTIONS: Patients were treated with either tianeptine (12.5mg three times daily) or paroxetine (20mg once daily plus two placeb …
Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial.
Anghelescu I, Szegedi A, Schlegel S, Weigmann H, Hiemke C, Wetzel H. Anghelescu I, et al. Eur Neuropsychopharmacol. 1998 Dec;8(4):315-20. doi: 10.1016/s0924-977x(97)00093-x. Eur Neuropsychopharmacol. 1998. PMID: 9928923 Clinical Trial.
After two measurements of serum concentrations of clozapine and metabolites during steady state conditions, an add-on therapy with 20 mg paroxetine was initiated. No concomitant medication was allowed. The main finding of our prospective study was that addition of parox
After two measurements of serum concentrations of clozapine and metabolites during steady state conditions, an add-on therapy with 20 mg …
A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.
Weiss M, Hechtman L; Adult ADHD Research Group. Weiss M, et al. J Clin Psychiatry. 2006 Apr;67(4):611-9. J Clin Psychiatry. 2006. PMID: 16669726 Clinical Trial.
OBJECTIVE: To determine the effect of psychotherapy, dextroamphetamine, and/or paroxetine on attention-deficit/hyperactivity-disorder (ADHD) in adults. METHOD: Ninety-eight adults with DSM-IV ADHD were randomly assigned to receive psychotherapy and dextroamphetamine, pa
OBJECTIVE: To determine the effect of psychotherapy, dextroamphetamine, and/or paroxetine on attention-deficit/hyperactivity-disorder …
[Clinical study of combined treatment of remifemin and paroxetine for perimenopausal depression].
Huang YX, Song L, Zhang X, Lun WW, Pan C, Huang YS. Huang YX, et al. Zhonghua Yi Xue Za Zhi. 2013 Feb 26;93(8):600-2. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23663341 Clinical Trial. Chinese.
OBJECTIVE: To explore the efficacies and safety of combined treatment of remifemin and paroxetine for perimenopausal depression. METHODS: A total of 120 patients with perimenopausal depression were digital randomly divided into the treatment and control groups (n = 60 each …
OBJECTIVE: To explore the efficacies and safety of combined treatment of remifemin and paroxetine for perimenopausal depression. METH …
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
Nardi AE, Valença AM, Freire RC, Mochcovitch MD, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O E Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M. Nardi AE, et al. Braz J Med Biol Res. 2011 Apr;44(4):366-73. doi: 10.1590/s0100-879x2011007500020. Epub 2011 Feb 18. Braz J Med Biol Res. 2011. PMID: 21344132 Free article. Clinical Trial.
Efficacy assessment included number of panic attacks and clinician ratings of the global severity of panic disorders with the clinical global impression (CGI) improvement (CGI-I) and CGI severity (CGI-S) scales. Most patients were females (69.8 and 68.4% in the clonazepam …
Efficacy assessment included number of panic attacks and clinician ratings of the global severity of panic disorders with the clinical globa …
1,133 results